JNJ-64281802

· Janssen Research & Development, LLC

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for JNJ-64281802, covering 2024-03-01 to 2025-07-31. Get the full timeline:

Most recent: Clinical Trial Update: A Study of JNJ-64281802 for the Prevention of Dengue Infection [Phase 2]